# FDA 483 - Jeffrey Lancet, M.D. - August 24, 2016

Source: https://www.keypedia.com/records/483/jeffrey-lancet-md/5acaa67e-f768-4b13-bd49-4fa48cf4d091

> FDA 483 for Jeffrey Lancet, M.D. on August 24, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jeffrey Lancet, M.D.
- Inspection Date: 2016-08-24
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: This FDA Form 483 was issued to Jeffrey Lancet, M.D. in Tampa, FL, following an inspection of their clinical investigator site. The inspection revealed significant repeat observations concerning failures to adhere to investigational plans and protocols, including missing subject safety data and unauthorized personnel consenting subjects, as well as issues with maintaining accurate case histories and data integrity.

## Related Officers

- [investigator](https://www.keypedia.com/people/gene-r-gunn/3c011052-9264-461e-a92e-4af3cc26819c)

Company: https://www.keypedia.com/companies/jeffrey-lancet-md/2a339d10-d087-4bb1-8bc7-3d36c751ed16

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6